IL23A and gastroenteritis: These findings are surprising considering previous studies of RORC inhibition in a variety of inflammatory models including antigen-induced arthritis (17), imiquimod-induced psoriasis (21), IL-23 induced skin inflammation (30), intestinal inflammation (22, 31).